The therapeutic action of Tumor Necrosis Factor (TNF) will be studied using spatially resolved, noninvasive Magnetic Resonance (MR) methods. The following model for the effect of TNF on solid tumors will be tested.' TNF causes rapid damage of tumor vasculature within 1 - 4 hours; the subsequent ischemia leads to cell death in the center of the tumor. The outer rim of the tumor is unaffected by the early ischemic episode, Cells in this region may be killed by a delayed (24 - 72 hours) response to TNF, but often survive, and repopulate the tumor. The experiments will be designed to Provide a practical understanding of the factors which lead to TNF-induced tumor regression.
The specific aims of the proposed work are: 1. Development and testing of MR methods: The ability of spatially resolved MR measurements of tumor blood flow and metabolism to detect hypoxia, necrosis, and hemorrhagic lesions will be developed and evaluated. 2. Therapeutic action of TNT: a) Importance of acute and delayed effects.- Murine Meth A tumors win be studied by MR at 4 hours, 24 hours, 72 hours, and 1 week after the beginning of treatment with TNF. The acute and delayed effects of TNF will be identified by MR on the basis of their effects on tumor blood flow, metabolite levels, and anatomy. The data wt be analyzed to determine the relative importance of the acute and delayed effects for causing tumor regression, and identify other factors which are important in causing tumor regression.. b) Resistant cell populations: MR will be used to identify those tumor zones in which cells survive the effects of TNF and may rePoPulate the tumor. Characterization of these cells may lead to improved treatment protocols. 3. Improved treatment protocols: Based data from the initial studies (above), modified schedules for administration of TNF, alone and in combination with other therapeutic agents, will be designed and evaluated using MR methods.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29CA052008-01A1
Application #
3459848
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1991-01-18
Project End
1995-12-31
Budget Start
1991-01-18
Budget End
1991-12-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Al-Hallaq, H A; River, J N; Zamora, M et al. (1998) Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 41:151-9
Kovar, D A; Al-Hallaq, H A; Zamora, M A et al. (1998) Fast spectroscopic imaging of water and fat resonances to improve the quality of MR images. Acad Radiol 5:269-75
Kovar, D A; Lewis, M; Karczmar, G S (1998) A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging 8:1126-34
Oikawa, H; al-Hallaq, H A; Lewis, M Z et al. (1997) Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med 38:27-32
Kovar, D A; Lewis, M Z; River, J N et al. (1997) In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors. Magn Reson Med 38:259-68
Karczmar, G; River, J; Koretsky, A P (1995) Radiofrequency magnetic field gradient echoes have reduced sensitivity to susceptibility gradients. Magn Reson Imaging 13:791-7
Kuperman VYu; River, J N; Lewis, M Z et al. (1995) Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn Reson Med 33:318-25
Karczmar, G S; Kuperman, V Y; River, J N et al. (1994) Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest Radiol 29 Suppl 2:S161-3
Karczmar, G S; River, J N; Li, J et al. (1994) Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed 7:3-11
Karczmar, G S; River, J N; Goldman, Z et al. (1994) Magnetic resonance imaging of rodent tumors using radiofrequency gradient echoes. Magn Reson Imaging 12:881-93